MyFinsight
Home
Blog
About
Accounts payable
$374K
(191.44%↑ Y/Y)
Accrued salaries and
bonus
$238K
(235.23%↑ Y/Y)
Lab supplies
write-off
$217K
Net income
$158K
(-84.31%↓ Y/Y)
Depreciation and
amortization
$127K
(-35.20%↓ Y/Y)
Amortization on operating
lease right of use...
$109K
(-43.52%↓ Y/Y)
Other long-term
liabilities
$108K
(-49.53%↓ Y/Y)
Deferred taxes
$62K
Other accrued
expenses
$15K
(103.74%↑ Y/Y)
Stock-based compensation
$4K
(-83.33%↓ Y/Y)
Net cash provided by
operating activities
$98K
(-94.42%↓ Y/Y)
Canceled cashflow
$1,314K
Net increase
(decrease) in cash and cash...
$41K
(104.28%↑ Y/Y)
Canceled cashflow
$57K
Other current assets
$795K
(250.22%↑ Y/Y)
Accounts receivable
$386K
(129.40%↑ Y/Y)
Operating lease
liabilities
-$133K
(28.11%↑ Y/Y)
Net cash used in
investing activities
-$57K
(71.64%↑ Y/Y)
Purchase of property and
equipment
$57K
(-71.64%↓ Y/Y)
Back
Back
Cash Flow
INTERPACE BIOSCIENCES, INC. (IDXG)
INTERPACE BIOSCIENCES, INC. (IDXG)
source: myfinsight.com